
    
      The success rate of currently recommended triple therapy with a proton pump inhibitor (PPI)
      plus amoxicillin and clarithromycin has fallen into the unacceptable range. The purpose of
      this study is to observe the efficacy of ten day triple therapy-based, bismuth-containing
      quadruple therapy for H.pylori treatment, while ten day triple therapy is used as control.
    
  